RAFAEL HOLDINGS, INC. Long-Lived Assets
RAFAEL HOLDINGS, INC. (RFL) had Long-Lived Assets of $1.71 million as of 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2023-06-13
- 2023-04-30: Long-Lived Assets $1.71M.
- 2023-01-31: Long-Lived Assets $1.73M.
- 2022-10-31: Long-Lived Assets $1.75M.
- 2022-07-31: Long-Lived Assets $1.77M.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2023-04-30 | $1.71M 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $1.73M 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $1.75M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $1.77M 10-Q · filed 2023-06-13 | |
| 2022-04-30 | $42.18M 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $1.77M 10-Q · filed 2023-03-14 | $42.54M 10-Q · filed 2022-03-17 |
| 2021-10-31 | $42.88M 10-Q/A · filed 2022-02-28 | |
| 2021-07-31 | $1.84M 10-K · filed 2022-10-31 | $43.24M 10-K · filed 2021-10-18 |
| 2021-04-30 | $43.59M 10-Q · filed 2021-06-14 | |
| 2020-07-31 | $44.43M 10-K · filed 2021-10-18 | |
| 2020-01-31 | $48.25M 10-Q · filed 2020-03-05 | |
| 2019-10-31 | $48.59M 10-Q · filed 2019-12-09 | |
| 2019-07-31 | $48.73M 10-Q · filed 2020-03-05 | |
| 2019-04-30 | $49.18M 10-Q · filed 2019-06-05 | |
| 2019-01-31 | $49.38M 10-Q · filed 2019-03-12 | |
| 2018-10-31 | $49.74M 10-Q · filed 2018-12-10 | |
| 2018-07-31 | $50.11M 10-K · filed 2019-10-04 | $72.41M 10-K · filed 2018-10-15 |
| 2018-04-30 | $70.89M 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $65.18M 10-Q · filed 2018-03-12 | |
| 2017-07-31 | $74.04M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |